LONG-TERM SAFETY OF CANAKINUMAB IN PATIENTS WITH AUTOINFLAMMATORY DISEASES - INTERIM ANALYSIS OF THE RELIANCE REGISTRY

Kuemmerle-Deschner JB, Henes J, Kortus-Goetze B, Kallinich T, Oommen P, Rech J, Krickau T, Weller-Heinemann F, Horneff G, Janda A, Foeldvari I, Schuetz C, Dressler F, Borte M, Hufnagel M, Meier F, Fiene M, Weber-Arden J, Blank N (2022)


Publication Type: Conference contribution

Publication year: 2022

Journal

Publisher: BMJ PUBLISHING GROUP

City/Town: LONDON

Pages Range: 1026-1027

Conference Proceedings Title: ANNALS OF THE RHEUMATIC DISEASES

DOI: 10.1136/annrheumdis-2022-eular.4903

Authors with CRIS profile

Involved external institutions

How to cite

APA:

Kuemmerle-Deschner, J.B., Henes, J., Kortus-Goetze, B., Kallinich, T., Oommen, P., Rech, J.,... Blank, N. (2022). LONG-TERM SAFETY OF CANAKINUMAB IN PATIENTS WITH AUTOINFLAMMATORY DISEASES - INTERIM ANALYSIS OF THE RELIANCE REGISTRY. In ANNALS OF THE RHEUMATIC DISEASES (pp. 1026-1027). LONDON: BMJ PUBLISHING GROUP.

MLA:

Kuemmerle-Deschner, J. B., et al. "LONG-TERM SAFETY OF CANAKINUMAB IN PATIENTS WITH AUTOINFLAMMATORY DISEASES - INTERIM ANALYSIS OF THE RELIANCE REGISTRY." Proceedings of the ANNALS OF THE RHEUMATIC DISEASES LONDON: BMJ PUBLISHING GROUP, 2022. 1026-1027.

BibTeX: Download